Table 1.
Examining the HCV Cascade of Care Through a Problem-Based Lens
Screening: | Linkage to care: | Treatment: | |||
---|---|---|---|---|---|
Barriers | Examples of solutions | Barriers | Examples of solutions | Barriers | Examples of solutions |
Knowledge of guidelines | Short course learning (online or in-person), integrate into trainee education | Referral to specialist | Co-localize diagnosis and treatment in primary care | Financial burden | Focus policy changes to cover HCV treatment to prevent long-term liver disease, utilize generics to decrease costs |
Patient not screened | Increase EMR-based reminders, increase education, utilize “opt-out” screening, utilize POC testing | Patient not interested in treatment | Increase public health awareness, educate in clinic and at health fairs | Difficulty in accessing treatment | Train non-specialists to treat HCV, decrease patient and provider restrictions for HCV treatment, decrease transportation needs, use of telemedicine platforms to access patients |
Patients not getting confirmatory test (HCV viral load) | Reflex testing of antibody-positive results, EMR-based reminders | Patient ineligible for treatment per state guidelines | Advocacy to remove all HCV treatment restrictions | Gaps in treatment course or failure to complete course of treatment | Dispense full course of medication at onset of treatment, engagement of pharmacists as treatment partners, patient reminders |
Patient not presenting to primary care setting | Take testing to populations most at risk for HCV and those who are unlikely to present to primary care provider | Loss to follow-up or missed appointments | Decrease amount of surveillance labs and office visits to reduce patient visit burden and cost |